Titan Pharmaceuticals, Inc. (TTNP) Financial Analysis & Valuation | Quarter Chart
Titan Pharmaceuticals, Inc. (TTNP)
TTNPPrice: $2.34
Fair Value: 🔒
🔒score
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in cl... more
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of ch... more
Description
Shares
| Market Cap | $3.11M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Biotechnology |
| Country | KY | CEO | Weei Jye Chay |
| IPO Date | 1996-01-18 | CAGR | — |
| Employees | 4 | Website | www.titanpharm.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
TTNP chart loading...
Fundamentals
Technicals
| Enterprise Value | $4.74M | P/E Ratio | -0.8 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 2.91 | P/B Ratio | — |
| P/CF Ratio | 9.88 | P/FCF Ratio | 28.81 |
| EPS | $-2.92 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -87.65% | Gross Margin | 0.33% |
| Operating Margin | 0.08% | Profit Margin | 0.08% |
| ROE | — | ROA | — |
| ROCE | 0% | Current Ratio | 0.3 |
| Quick Ratio | 0.3 | Cash Ratio | 0.02 |
| Debt/Equity | 0.04 | Interest Coverage | 16.26 |
| Altman Z Score | -240.61 | Piotroski Score | 1 |